Zim Laboratories Ltd - 541400 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We are enclosing herewith Certificate dt. 10.07.2020 issued by Link Intime India Private Limited, Mumbai, Registrar and Transfer Agent (RTA) of the company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. This is for your information and record. Zim Laboratories Ltd - 541400 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
We wish to inform you that the Company has allotted 61,216 equity shares of Rs.10/- each,on July 11, 2020 pursuant to the Employees Stock Option Scheme of the Company. Kindly take the above information on record. Zim Laboratories Ltd - 541400 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release for Submission of Marketing Authorization Application for Rizatriptan orally dissolving film in Europe. Please find enclosed herewith our Press Release relating to Marketing Authorization Application for Rizatriptan orally dissolving film in Europe. This is for your information and record. Zim Laboratories Ltd - 541400 - Closure of Trading Window
This is to inform you that pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015, BSE Circular No. LIST/COMP/2019-20 dt. 02nd April, 2019, and Company's Code of Conduct to Regulate, Monitor and Report Trading by Insider's, the trading window for dealing with securities of the Company will remain closed from Wednesday, the 01st July 2020, for 'Designated Persons', including Promoters/ Directors/ Key Managerial Personnel/Designated employees of the company and their immediate relatives. The Trading Window shall open after 48 hours of declaration of financial results of the company for the quarter ended 30th June, 2020. Zim Laboratories Ltd - 541400 - Declaration With Respect To Non-Applicability Of Larger Corporate Framework.
Pursuant to SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 dated 26th November, 2018 for fund raising by issuance of debt securities by larger entities and compliance thereof, we hereby declare that our company is out of purview of Larger Corporate (LC) category as per the applicability of framework provided in above mentioned circular. Kindly take the intimation on record Zim Laboratories Ltd - 541400 - Disclosure Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
In compliance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the disclosure of Related Party Transactions on a consolidated basis for the half year ended March 31, 2020 Zim Laboratories Ltd - 541400 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Grant Of US Patent To ZIM Labs.
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we would like to inform you that the company has been issued a new U.S. patent for the invention of 'Pharmaceutical Microemulsions Immobilized In A Thin Polymer Matrix And Methods Of Making Same'. The technology has been developed by the company and registered in the United States Patent and Trademark Office under the number US 10, 660,862 B2. Zim Laboratories Ltd - 541400 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of Newspaper Publication regarding Financial Results for the quarter and year ended as on 31.03.2020 in "Financial Express" (English) and "Loksatta" (Marathi) newspapers published on 03.06.2020. Zim Laboratories Ltd - 541400 - Outcome Of Board Meeting
This is to inform you that the Board of Directors in their meeting held today has inter-alia considered and approved: 1) the Audited Financial Statements (Standalone and Consolidated) of the Company for the year ended 31st March, 2020. 2) the Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended 31st March, 2020 (prepared pursuant to SEBI (LODR) Regulations, 2015). Walker Chandiok & Co LLP, Chartered Accountants, the Statutory Auditors of the company have issued auditor's report with an unmodified opinion on the financial results for the year ended 31.03.2020. The Board Meeting commenced at 03.30 p.m. and concluded at 06.15 p.m.